Multiplex PCR Assay for MRSA and Staphylococcus Species Differentiation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for identifying and differentiating methicillin-resistant Staphylococcus aureus (MRSA) and other related species, such as methicillin-resistant Staphylococcus epidermidis (MRSE), are slow, cumbersome, and primarily focused on MRSA, lacking the accuracy and speed needed for effective screening and diagnosis, especially in healthcare settings.
Innovation Solution
A multiplex assay system utilizing specific gene sequences, primers, and probes targeting mecA, femA, tuf, and nuc genes to identify and differentiate MRSA, MSSA, MRSE, MRCNS, and MSCNS, allowing for rapid and accurate identification in mixed specimens.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Speed
If traditional culturing methods are used for identifying MRSA, then the identification can be performed with simple equipment, but the process is slow and time-consuming
Solution Approach 1:
The patent replaces traditional mechanical culturing methods with a molecular biology-based multiplex PCR assay system. This substitution uses DNA amplification and detection technologies to identify MRSA, MSSA, MRSE, and other staphylococcal species directly from clinical samples, eliminating the need for prolonged culturing while providing rapid results within hours.
Solution Approach 2:
The multiplex assay system simultaneously performs multiple functions: it identifies different staphylococcal species (S. aureus, S. epidermidis, CNS), determines methicillin resistance status (MRSA vs MSSA, MRSE vs MSSE), and differentiates coagulase-positive from coagulase-negative staphylococci all in a single test, replacing multiple separate traditional methods.
2Adaptability or versatility
If current identification systems focused only on MRSA are used, then the testing procedure is simpler, but the ability to differentiate other species like MRSE and MRCNS is lost
Solution Approach 1:
The assay incorporates multiple primer and probe sets targeting species-specific genetic sequences (nuc gene for S. aureus, femA gene for S. epidermidis, tuf gene for CNS) within a single multiplex reaction system, enabling simultaneous identification of multiple staphylococcal species and their methicillin resistance status.
Solution Approach 2:
The identification system is divided into distinct genetic target segments: the nuc gene region for S. aureus detection, the femA gene region for S. epidermidis detection, the tuf gene region for CNS detection, and the mecA gene region for methicillin resistance detection. Each segment is targeted by specific primers and probes that can be combined in various multiplex configurations.
3Measurement precision
If rapid identification methods are implemented, then screening efficiency improves, but the accuracy and reliability of differentiation may be compromised
Solution Approach 1:
The patent employs real-time PCR technology with fluorescent probe detection to replace traditional phenotypic identification methods. This allows for rapid amplification and detection of species-specific and resistance gene sequences within hours, maintaining high accuracy through specific primer-probe interactions while dramatically reducing testing time compared to culturing methods that take days.
Solution Approach 2:
The multiplex assay incorporates internal controls and uses fluorescent signal feedback during the PCR amplification process to monitor reaction progress and confirm successful amplification of target sequences. The presence or absence of specific fluorescent signals provides immediate feedback on the identification results, ensuring accuracy while maintaining rapid turnaround.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system enables rapid and accurate differentiation of these bacterial species, improving screening and diagnosis efficiency and reducing the risk of infections by providing a more informative and sensitive testing method compared to traditional culturing techniques.
Implementation Method 1
Kilic et al. (2010) Diagnostic Microbiology and Infectious Disease 66, 349-355 describes a triplex real-time polymerase chain reaction assay for simultaneous detection of Staphylococcus aureus and coagulase-negative staphylococci and determination of methicillin resistance directly from positive blood culture bottles.
Data Source
AI summary
The present invention provides multiplex assays, methods and kits that may be used to detect and confirm the presence of MRSA in a sample. The methods include real-time PCR assays, and the kits and compositions include oligonucleotides used as primers and probes. The present invention further comprises assays useful to identify and differentiate MRSA, MSSA, MRSE, MSSE, MRCNS and MSCNS in a sample.